Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension
Open Access
- 1 January 2013
- journal article
- Published by Springer Science and Business Media LLC in Respiratory Research
- Vol. 14 (1), 130
- https://doi.org/10.1186/1465-9921-14-130
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Pathophysiology of Lower Extremity Edema in Acute Heart Failure RevisitedThe American Journal of Medicine, 2012
- Increased Sympathetic Nerve Activity in Pulmonary Artery HypertensionCirculation, 2004
- Neuroendocrine Control of Body Fluid MetabolismPhysiological Reviews, 2004
- Science Review: Vasopressin and the cardiovascular system part 1 – receptor physiologyCritical Care, 2003
- Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the registry of studies of left ventricular dysfunctionJournal of the American College of Cardiology, 1994
- Atrial natriuretic peptide in heart failureJournal of the American College of Cardiology, 1993
- Survival in Patients with Primary Pulmonary HypertensionAnnals of Internal Medicine, 1991
- Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man.JCI Insight, 1986
- Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin–neurophysin II precursorNature, 1982
- Development and Clinical Application of a New Method for the Radioimmunoassay of Arginine Vasopressin in Human PlasmaJCI Insight, 1973